| 000 | 01736 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515163225.0 | ||
| 264 | 0 | _c20090504 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a0161-6412 | ||
| 024 | 7 |
_a10.1179/174313209X393898 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang, Jin | |
| 245 | 0 | 0 |
_aAlbumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats. _h[electronic resource] |
| 260 |
_bNeurological research _cMar 2009 |
||
| 300 |
_a189-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlbumins _xtherapeutic use |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
| 650 | 0 | 4 |
_aBrain Edema _xdrug therapy |
| 650 | 0 | 4 |
_aBrain Injuries _xdrug therapy |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 |
_aCell Count _xmethods |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadverse effects |
| 650 | 0 | 4 |
_aIn Situ Nick-End Labeling _xinstrumentation |
| 650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeurologic Examination |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReperfusion Injury _xchemically induced |
| 650 | 0 | 4 | _aTetrazolium Salts |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadverse effects |
| 700 | 1 | _aLi, Ya-Jun | |
| 700 | 1 | _aMu, Jun | |
| 700 | 1 | _aLi, Qi | |
| 700 | 1 | _aYang, De-Yu | |
| 700 | 1 | _aXie, Peng | |
| 773 | 0 |
_tNeurological research _gvol. 31 _gno. 2 _gp. 189-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1179/174313209X393898 _zAvailable from publisher's website |
| 999 |
_c18737025 _d18737025 |
||